期刊文献+

转录因子Sp1上调前列腺癌细胞中CD59的表达(英文)

Identification of transcription factor Sp-1 up-regulating the expression of CD59 in prostate cancer
原文传递
导出
摘要 目的:构建针对Sp1基因siRNA真核表达载体,转染前列腺癌细胞PC-3,研究反式作用因子Sp1对CD59表达的影响。方法:应用siRNA表达载体介导的RNAi技术,构建含特异性Sp1基因的重组载体pSUPER-siSp1,脂质体法转染前列腺癌细胞,G418 筛选建立稳定表达转染基因的细胞株,Western blotting 检测转染细胞中 Sp1 和 CD59 基因的表达,MTT 和染料释放试验判断CD59基因抑制后对补体溶破的抵抗作用。结果:成功构建了Sp1基因siRNA真核表达载体,转染PC-3细胞可表达荧光蛋白,稳定转染的PC-3细胞Sp1及CD59基因蛋白水平降低,MTT和染料释放实验表明CD59基因受抑制后对补体溶破的抵抗作用降低。结论:siRNA-Sp1重组载体有效地抑制了CD59的表达,降低CD59的抗补体活性,结果证明反式作用因子Sp1是CD59表达调控中重要的转录因子,为探讨CD59在肿瘤细胞中高表达的研究奠定了基础。 Objective: To construct recombinant vectors expressing siRNA that target Sp1 gene and a stable-inhibit cell line PC-3 in order to analyze the role of Sp1 in the expression of CD59. Methods: The 63 bp encoded targeting Sp1 gene shRNA sequence was cloned and transferred into pSUPER vector by DNA recombinant technique. The prostate cancer cell PC-3 was transfect with this recombinant plasmid by liposome and the stable strains was selected by G418 medium. Sp1 and CD59 protein was detected by Western blotting, and its function was detected by dye release assay. Results: The pSUPER-siRNA expressing vector was successfully constructed, and a stable cell line PC-3 was selected and detected the expression of GFP. The siRNA vector effectively inhibited the CD59 gene expression from protein in level. MTT assay and Dye release assay suggested that CD59's protection to complement mediated cytolysis decreased. Conclusion: The siRNA vector targeting Sp1 gene could consistently inhibit CD59 expression. Furthermore, it decreased CD59's protection against complement. These results may pave the way for studying the role of Sp1 in the expression of CD59.
出处 《现代生物医学进展》 CAS 2010年第20期3807-3811,共5页 Progress in Modern Biomedicine
基金 supported by National Natural Science Foundation of China (30972677)~~
关键词 CD59 启动子 Sp1转录因子 RNA干扰 CD59; Complement; Promoter Regions Genetic; RNA Interference; Sp1Transcription Factor;
  • 相关文献

参考文献10

  • 1Kimberley FC,Sivasankar B,Morgan BP.Alternative roles for CD59[].Molecular Immunology.2007
  • 2Jarvis GA,Li J,Hakulinen Jet al.Expression and function of the complement membrane attack complex inhibitor protectin (CD59) in human prostate cancer[].International Journal of Cancer.1997
  • 3Wang L,Guan X,Zhang Jet al.Targeted inhibition of Sp1-mediated transcription for antiangiogenic therapy of metastatic human gastric cancer in orthotopic nude mouse models[].International Journal of Oncology.2008
  • 4Filips M,Pohl G,Rudfas Met al.Clinical role of multidrug resis- tance Protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group[].Clinical Oncology.2005
  • 5Plaisance V,Niederhauser G,Azzouz Fet al.The repressor element silencing transcription factor (REST) mediated transcriptional repres- sion requires the inhibition of Sp1[].Biological Chemistry.2005
  • 6Donev RM,Gray LC,Sivasankar B,Hughes TR,van den Berg CW,Morgan BP.Modulation of CD59 expression by restrictive silencer factor-derived peptides in cancer immunotherapy for neuroblastoma[].Cancer Research.2008
  • 7Rushmere,NK,Knowlden,JM,Gee,JM,Harper,ME,Robertson,JF,Morgan,BP,Nicholson,RI.Analysis of the level of mRNA expression of the membrane regulators of complement, CD59, CD55 and CD46, in breast cancer[].International Journal of Cancer.2004
  • 8Jemal A,Siegel R,Ward E, et al.Cancer statistics, 2006[].CA A Cancer Journal for Clinicians.2006
  • 9Pore N,Liu S,Shu HK,et al.Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism[].Molecular Biology.2004
  • 10Golay J,Lazzari M,Facchinetti V. et al.CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia:further regulation by CD55 and CD59[].Blood.2001

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部